ArticleScientific reports2026
Green synthesis of silver nanoparticles from Buddleja asiatica L. and their multifunctional applications for industrial and bio-based products.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology provides innovative solutions to biomedical and agricultural challenges, and silver nanoparticles (AgNPs) are of particular interest due to their broad-spectrum bioactivity. This study aimed to green-synthesize AgNPs using Buddleja asiatica leaf extract, characterize the nanoparticles, and evaluate antibacterial, antioxidant, anticancer, and phytotoxic/phytostimulatory activities. AgNP formation was confirmed by UV-visible spectroscopy (SPR peak at 420 nm). XRD verified a crystalline face-centered cubic structure, while SEM showed predominantly near-spherical nanoparticles (10-22 nm). FTIR indicated plant-derived functional groups involved in stabilization. Biologically, BA-AgNPs exhibited strong antibacterial activity against a Gram-positive clinical isolate (Streptococcus sp.) and Gram-negative bacteria, with the largest inhibition zone of 14 ± 0.57 mm at 0.9 mg/mL. Antioxidant activity reached 88.12% DPPH scavenging at 100 ppm, compared with 80.90% for ascorbic acid under the same assay conditions. BA-AgNPs showed concentration-dependent cytotoxicity in RD cells, with cell death ranging from 87.00% at 100 mg/mL to 5.33% at 0.39062 mg/mL; however, IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.